← FDA DRUG APPROVALS

FDA ANDA · ANDA040747

BENZPHETAMINE HYDROCHLORIDE

Sponsor: TEDOR PHARM

APPLICATION
ANDA040747
TYPE
ANDA
ORIGINAL APPROVAL
2007-03-30
LATEST ACTION
2015-11-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BENZPHETAMINE HYDROCHLORIDEDiscontinued
BENZPHETAMINE HYDROCHLORIDE 25MG · TABLET · ORAL
BENZPHETAMINE HYDROCHLORIDEDiscontinued
BENZPHETAMINE HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2015-11-20Manufacturing (CMC) · Supplement 6AP
2011-05-31Labeling · Supplement 5AP
2007-03-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →